Rare diseases
Investigational molecules
Locations
Back to France1 417 clinical trials in Beuvry, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
FranceA study to evaluate the efficacy and safety of zenagamtide in people with obesity
FranceEfficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial
FranceA study evaluating glofitamab and a drug combination for patients with relapsed or refractory diffuse large B-cell lymphoma.
FranceStudy of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab
FranceStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
FranceStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
FranceA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
FranceLong-term study of sotatercept added to standard treatment in patients with pulmonary arterial hypertension
FranceA Study of Lifileucel with Cyclophosphamide, Fludarabine, and Aldesleukin for Adults with Previously Treated Advanced Melanoma
FranceA Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
FranceStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on gastrointestinal cancers, including studies evaluating novel treatments for esophageal squamous cell carcinoma and advanced colorectal cancer. Research includes innovative combination therapies and targeted treatments for specific genetic mutations.
Innovative studies examining treatments for non-small cell lung cancer, including immunotherapy combinations and radiation therapy approaches. Research focuses on improving outcomes for patients with advanced disease stages.
Comprehensive research into hormone-dependent cancers, investigating new treatment approaches for castrate-resistant prostate cancer and ER+/HER2- breast cancer. Studies include both early-stage and advanced disease management.
Studies examining treatments for respiratory tract infections and severe infections in intensive care settings. Research includes antibiotic alternatives and management strategies for septic shock.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
